Treatment of Huntington disease with a cholinergic agonist

Publisher Website
Google Scholar
Abstract
The involuntary movements of Huntington disease may be related to cholinergic hypofunction in the striatum. For this reason, the effect of a direct cholinergic agonist, arecoline, was studied in 6 patients with this disorder. Rather than improving the chorea, arecoline tended to exacerbate the choreic movements. Arecoline did produce significant alterations of blood pressure, heart rate and body temperature, probably by central cholinergic stimulation.

This publication has 1 reference indexed in Scilit: